71% of Daylight users in the study achieved and maintained remission of Generalized Anxiety Disorder (GAD) by week 10 follow-up, compared to 33% of controls.

Big Health announces $39MM in Series B financing led by Gilde Healthcare and Morningside Ventures; existing investors Kaiser Permanente Ventures & Octopus Ventures.

A health economic evaluation of Sleepio was conducted at a Fortune 500 company in collaboration with IBM Watson Health. The cohort of Sleepio users had 28% lower healthcare costs.

Big Health and NHS England to provide all staff across England with free access to mental health apps Daylight and Sleepio during the COVID-19 pandemic.

Former NHS Medical Director Sir Bruce Keogh Joins Big Health Advisory Board

CVS Health today announced that Big Health's 24-hour mental health solution — Sleepio for poor sleep, and Daylight for worry and anxiety — is now available to employers and other plan sponsors through CVS Caremark’s Point Solutions Management program.